Initially, SMARCAL1‐mediated regulation of PD‐L1 in cancer patients could not be fully mimicked due to the study's heavy reliance on preclinical models, and the fact that SMARCAL1 does not affect the levels of PD‐L1 in mouse cells. Here, CD274 is linked to cancer.